Grassley to hold drug pricing hearing

Grassley to hold drug pricing hearing
© Stefani Reynolds

The Senate Finance Committee's first hearing of the year will focus on prescription drug prices, panel chairman Sen. Chuck GrassleyCharles (Chuck) Ernest GrassleyOn The Money: Inside the Mueller report | Cain undeterred in push for Fed seat | Analysis finds modest boost to economy from new NAFTA | White House says deal will give auto sector B boost The 7 most interesting nuggets from the Mueller report Government report says new NAFTA would have minimal impact on economy MORE (R-Iowa) announced Tuesday.

The Jan. 29 hearing "will be the first in a series of hearings scrutinizing prescription drug pricing and considering policy and oversight solutions to lower costs for American patients," Grassley said in a statement Tuesday.

"We already know what the problem is. It’s time to look at bipartisan solutions and work to turn them into law,” he added.

The Senate hearing will be the same day the Democratic-led House Oversight and Reform Committee holds the first of its own drug pricing hearings.

ADVERTISEMENT

The two hearings on the same day shows the bipartisan nature of the concern over rising drug prices.

Grassley and House Oversight and Reform Committee Chairman Elijah CummingsElijah Eugene CummingsElijah Cummings: 'I am begging the American people to pay attention to what's going on' Nadler: We will subpoena the entire Mueller report early Friday Dem House chairs: Mueller report 'does not exonerate the president' MORE (D-Md.) have made rising drug prices a central concern.

Grassley is largely seen as a dogged investigator who backs free-market principles, and is not seen as an ally of the pharmaceutical industry.

He is also willing to work with Democrats. In September he teamed up with Sen. Dick DurbinRichard (Dick) Joseph DurbinDurbin calls Mueller report findings on Trump team 'troubling' Congress opens door to fraught immigration talks McConnell: 'Past time' for immigration-border security deal MORE (D-Ill.) to legislate that television advertisements for drugs be accompanied by price disclosures. The measure was ultimately blocked by House Republicans.

Earlier this month, Grassley laid out his priorities for drug pricing action, including legislation with Sen. Amy KlobucharAmy Jean KlobucharSanders announces first endorsements in South Carolina Telehealth is calling — will Congress pick up? 2020 Dems call on Mueller to testify about redacted report MORE (D-Minn.) that would allow patients to import prescription drugs from Canada.

He has also expressed support for much of President TrumpDonald John TrumpGrassroots America shows the people support Donald Trump Trump speaks to rebel Libyan general attacking Tripoli Dem lawmaker: Mueller report shows 'substantial body of evidence' on obstruction MORE's drug pricing agenda.